equine COVID-19 antiserum F2 (Serum Institute of India)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameequine COVID-19 antiserum F2 (Serum Institute of India)
Drug Alias NameAnti-SARS-CoV-2 Equine Immunoglobulin F(ab')2 Fragment (Serum Institute of India)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionImmunoglobulin agonists
TargetsImmunoglobulin
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSerum Institute Of India Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSerum Institute Of India Pvt Ltd
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A